Neurostimulation
Neurostimulation is a medical device with 14 clinical trials. Currently 5 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
5
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Personalized Real-Time DBS and PD Mechanisms
Optimal Stimulation Parameters to Disrupt Epileptiform Activity
Evaluation of the Restera™ Serene™ System in Adults With Obstructive Sleep Apnea
Brain Stimulation and Decision-making
Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
Clinical Trials (14)
Personalized Real-Time DBS and PD Mechanisms
Optimal Stimulation Parameters to Disrupt Epileptiform Activity
Evaluation of the Restera™ Serene™ System in Adults With Obstructive Sleep Apnea
Brain Stimulation and Decision-making
Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms
Evaluation of the Analgesic Efficacy of an Ultrasound-guided Transperineal Pudendal Block in Outpatient Hemorrhoidal Surgery
Neurostimulation for Respiratory Function After Spinal Cord Injury
Burst Neurostimulation for Discogenic Low Back Pain
Neural Stimulation for Hand Grasp in People With Tetraplegia
Identifying the Optimal Neural Target for Misophonia Interventions
Physiological Changes With SPG Stimulation in Migraine Patients
Neural Stimulation for Hand Grasp
SPG Neurostimulation in Cluster Patients
STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy
All 14 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 14